Article

Conditional silencing of H-2Db class I molecule expression on dendritic cells modulates…

medRxiv · 2019 · Tritz, Z. P.; Orozco, R. C.; Malo, C. S.; Yokanovich, L. T.; Ayasoufi, K.; Fain, C. E.; Khadka, R. H.; Settell, M. L.; Hansen, M. J.; Jin, F.; Johnson, A. J.

Key facts

Title Conditional silencing of H-2Db class I molecule expression on dendritic cells modulates the protective and pathogenic kinetics of virus-antigen specific CD8 T cell responses during Theiler’s Virus infection
First author Tritz, Z. P.; Orozco, R. C.; Malo, C. S.; Yokanovich, L. T.; Ayasoufi, K.; Fain, C. E.; Khadka, R. H.; Settell, M. L.; Hansen, M. J.; Jin, F.; Johnson, A. J.
Journal medRxiv
Published May 9, 2019
DOI 10.1101/632265
Devices mentioned K964875
Product codes mentioned GQH, IDO, IDW, IDZ, IEO, KDT, KEQ, KER, KES, KIM, KIO, MVU and 4 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature